EDITORIAL SECTION
-
STRATEGY
Smarter Pharma
Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solution
-
CLINICAL TRIALS
Why Clinical Trials Need Digital Endpoints
According Citeline the average success rate for bringing a Phase candidate to market has dropped to an alltime low of just
-
MANUFACTURING
Ensuring Quality and Compliance in Biopharma
Ensuring quality and regulatory compliance in the biopharmaceutical industry is critical to safeguarding product safety and efficacy
-
Information Technology
The Cost of Bad Data
Modern pharmaceutical research generates an unprecedented volume of information Data from genomic sequencing
-
Biopharma
Reimagining Global Biomanufacturing Capacity with Continuous and Modular Systems
Biotechnology is fueling the ongoing expansion of the global market for a broad array of goods
-
EXPERT Talk
Compliance to Competitive Advantage in Pharma Supply
Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser
Advisory Board
KNOWLEDGE BANK
-
Articles
Using Mass Spectrometry as Quality Control in Medicinal Cannabis
Cannabis plants contain a wide variety of complex compounds including phytocannabinoids terpenoids and flavonoids found mainly in the inflorescences Major phytocannabinoids like CBD and THC have beneficial effects on human health
Maximizing ROI: The Secret to Successful Pharma Magazine Advertising
Advertisement through pharma magazines has for a long time remained common in most marketing strategies for pharma industries Its been around and it provides the best chance to engage with pharma professional other industry players and even a wellinformed populace However more especially given that the modern world is a digital realm there are always issues pertaining to the effectiveness of such...
Pain Points and Progress: Navigating the Complexities of Life Sciences Logistics
Within recent years there has been a new facet of complexity in the supply chain pathways of the life sciences industry From rising geopolitical tensions to trade wars logistics teams now have to operate in an environment shaped by rapid change regulatory scrutiny and unpredictable policy changes influenced by politics
How M&A Is Reshaping Europe’s Pharmaceutical Pipeline
For most of the past halfcentury a European drugmakers future was written in its own laboratories That model has not disappeared but it has been joined and in many boardrooms overtaken by a second engine of growth the acquisition of externally discovered science
Implementing Quality by Design (QbD) in Pharmaceutical Development: Enhancing Product Quality and Regulatory Compliance
Quality by Design QbD stands as a systematic strategy for pharmaceutical development prioritizing predefined product objectives and emphasizing a thorough understanding of both the product and its manufacturing processes This proactive approach integrates quality seamlessly into the development process championing a sciencedriven
Pharma ABM Strategies for B2B Growth: Precision Targeting for Key Accounts
The pharmaceutical industry is making significant strides changing the way that company ies are identified engaged and converted into high value business customers In todays datadriven competitive world traditional mass marketing strategies are no longer effective In todays day and age pharmaceutical companies are embracing very personalized relationships ROI measurement and the expansion of their...
-
Techno Trends
Alume Biosciences Secures FDA Breakthrough Therapy Designation for Bevonescein
Alume Biosciences has received Breakthrough Therapy Designation BTD from the US Food and Drug Administration FDA for bevonescein an investigational fluorescent drug being developed to support realtime nerve visualisation during head and neck surgery in adults Bevonescein is an intravenous fluorescent peptidedye conjugate that binds to nerve tissue
-
Projects
SK pharmteco Plans More Than US$200 Million Investment in Small Molecule and Peptide Manufacturing
SK pharmteco is planning a fiveyear investment of more than US million to expand and modernise its pharmaceutical development and manufacturing operations in the United States The programme will strengthen capabilities for small molecules and peptides while supporting a more
-
Research Insights
A drug repurposing screen reveals dopamine signaling as a candidate therapeutic pathway for PIGA-CDG
PIGACDG is a congenital disorder of glycosylation caused by pathogenic partial lossoffunction variants in the PIGA gene PIGA encodes an enzyme responsible for the catalytic transfer of Nacetylglucosamine
-
whitepaper
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys
TOP ARTICLES
-
1
Maximizing ROI: The Secret to Successful Pharma Magazine Advertising
Kate Williamson
Print media particularly magazines continue to offer a valuable way of reaching a well-inspected, informed audience mostly within the pharma sector. Ultimately, through identifying the audience, telli...
-
2
Pain Points and Progress: Navigating the Complexities of Life Sciences Logistics
Vincent Howard
Rising geopolitical tensions and trade wars are adding to the complexity in the life sciences supply chain. This article looks at how logistics teams are tackling these challenges, from geopolitical i...
-
3
How M&A Is Reshaping Europe’s Pharmaceutical Pipeline
Lakshmi
Europe’s pharmaceutical leaders are increasingly buying the innovation they once built in-house. This article examines how mergers and acquisitions (M&A) are reshaping Europe’s pharmac...
-
4
Implementing Quality by Design (QbD) in Pharmaceutical Development: Enhancing Product Quality and Regulatory Compliance
Kate Williamson
This article explores the implementation of Quality by Design (QbD) in pharmaceutical development, emphasizing its principles and practical applications. QbD ensures consistent product quality, reduce...
-
5
Pharma ABM Strategies for B2B Growth: Precision Targeting for Key Accounts
Kate Williamson
Pharma Account Based Marketing (ABM) is revolutionizing how Pharmaceutical companies grow and market their products by letting them target high-value accounts, communicate with them in a personalized...
press releases Read more...
Enveda Collaborates with Anthropic to Accelerate Drug Development
Enveda a biotechnology company using AI to translate natures chemistry into new medicines today announced results from its collaboration with Anthropic to streamline critical documentation processes in drug development Working with Claude Enveda developed AIenabled workflows to review Good Manufactu...
Pythia Labs Launches with AI-Designed Antibodies for Hard-to-Drug Targets
Pythia Labs a biotechnology company building frontier AI models for therapeutic discovery today announced its launch alongside a preprint in bioRxiv introducing Pythia the allatom generative model at the core of its antibody design platform Pythias technology is built to create antibodies against ta...
Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer
Genmab AS and Incyte announced a clinical trial collaboration to evaluate petosemtamab Genmabs investigational IgGbispecific antibody targeting the epidermal growth factor receptor EGFR and leucinerich repeat containing Gproteincoupled receptor LGR in combination with INCB Incytes investigational p...
CasZyme and Cirena to Collaborate on Developing Longer Guide RNAs to Optimise Cas12l Performance
CasZyme and Cirena have today signed an agreement that will see the two companies collaborate on further optimising the editing efficiency of CasZymes Casl CRISPR nuclease in humanrelevant applications using Cirenas synthetic nt guide RNAs
Events Read more...
28 - 30
Oct 2026BIOPLUS-INTERPHEX KOREA 2026
COEX, Seoul
02 - 04
Nov 2026Pharma Forum EMEA 2026
Dom Pedro Lisboa Hotel, Lisbon...
02 - 04
Nov 2026Cancer R&D 2026
Houston, TX, USA
03 - 05
Nov 202610th Dermatology Drug Development
Boston, Massachusetts at The C...
03 - 04
Nov 2026PDA Aseptic Processing of Biopharma Conference
Sheraton Grand Incheon Hotel,...
04 - 05
Nov 2026Advanced Therapies USA
Hynes Convention Center, Bosto...
05 - 05
Nov 2026PDA Contamination Control Strategy Workshop
Sheraton Grand Incheon Hotel,...
09 - 11
Nov 202611th Microbiome Movement USA Summit
The Colonnade Hotel, Boston, M...
LATEST NEWS Read more...
Roche strengthens cancer diagnostic portfolio with launch of test for differential diagnosis of mesothelioma
Roche announced today the global launch of the VENTANA BAP SP test This automated readytouse immunohistochemistry IHC assay provides a reliable highly specific diagnostic tool to help clinicians and pathologists accurately identify mesothelioma and distinguish it from other malignancies including no...
Stevanato Group and Aptar Pharma Collaborate to Help Accelerate Pre-Filled Syringe System Selection
Stevanato Group SpA a leading global provider of drug containment drug delivery and diagnostic solutions to the pharmaceutical biotechnology and life sciences industries today announced a collaboration with Aptar Pharma to provide systemlevel data supporting earlier evaluation of prefilled syringe c...
Sacituzumab Tirumotecan (Sac-TMT) Reduced the Risk of Death by 32% and the Risk of Disease Progression or Death by 41% Compared to Chemotherapy in Patients With Recurrent Endometrial Cancer
Merck known as MSD outside of the United States and Canada today announced the first presentation of results from the pivotal Phase TroFuse trial evaluating sacituzumab tirumotecan sacTMT an investigational TROPdirected antibodydrug conjugate ADC being developed in collaboration with KelunBiotech i...
Tempus Receives IVDR Certification for xR RNA Sequencing for Solid Tumor Profiling
Tempus AI Inc announced that its xR assay has received certification under the European Unions In Vitro Diagnostic Regulation IVDR as a Class C in vitro diagnostic device The certification covers Tempus quality management system for nextgeneration sequencing devices for cancer genomic profiling to s...
Georgiamune and Menarini Group Enter Exclusive Global License and Collaboration Agreement for GIM-621, a First-in-Class Oral Immuno-Oncology Agent
The Menarini Group a leading international pharmaceutical and diagnostics company and Stemline Therapeutics Inc Stemline a whollyowned subsidiary of the Menarini Group focused on bringing transformational oncology treatments to cancer patients along with Georgiamune Inc a clinicalstage biotechnology...
LGM Pharma Acquires Sannova Analytical, Expanding cGMP Analytical and GLP Bioanalytical Services
LGM Pharma a leading provider of tailored API sourcing contract analytical testing and drug development services today announced it has acquired Sannova Analytical a contract research laboratory headquartered in Somerset NJ The acquisition expands LGM Pharmas analytical testing services business by...






